Article: A Novel Solution for the High Defibrillation Threshold in Patients with a DF-4 Lead: Adding a High Voltage Adaptor/Splitter

A high defibrillation threshold occurs in approximately 6% of implants. The defibrillation threshold can be improved by addition of a defibrillation lead. However, the DF-4 high energy ICD header precludes the addition of a defibrillation lead. Here we report on use of a new high voltage adaptor/splitter that enables the addition of an extra defibrillation lead.

Citing Articles

DF-4 Lead Connector: Innovative Technology, Unexpected Problems and Novel Solutions.

Bhargava K Indian Pacing Electrophysiol J. 2014; 14(3):108-11.

PMID: 24920868 PMC: 4032777. DOI: 10.1016/s0972-6292(16)30751-3.

References

1.

Russo A, Sauer W, Gerstenfeld E, Hsia H, Lin D, Cooper J . Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?. Heart Rhythm. 2005; 2(5):456-61. DOI: 10.1016/j.hrthm.2005.01.015. View

2.

Sticherling C, Burri H . Introduction of new industry standards for cardiac implantable electronic devices: balancing benefits and unexpected risks. Europace. 2012; 14(8):1081-6. PMC: 3404557. DOI: 10.1093/europace/eus034. View

3.

Cantillon D, Ha K, Styperek R, Jumrussirikul P, Mirro M, Wong W . Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study. Pacing Clin Electrophysiol. 2013; 36(7):855-62. DOI: 10.1111/pace.12130. View

4.

Kashani A, Barold S . Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol. 2005; 46(12):2183-92. DOI: 10.1016/j.jacc.2005.01.071. View

5.

Cogert G, Cameron C, Sandler D . Limitations of the DF-4 defibrillator connector necessitating device removal. Pacing Clin Electrophysiol. 2010; 35(1):e24-6. DOI: 10.1111/j.1540-8159.2010.02873.x. View

6.

Osswald B, de Simone R, Most S, Tochtermann U, Tanzeem A, Karck M . High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?. Eur J Cardiothorac Surg. 2009; 35(3):489-92. DOI: 10.1016/j.ejcts.2008.10.021. View

7.

Dopp A, Miller J, Tisdale J . Effect of drugs on defibrillation capacity. Drugs. 2008; 68(5):607-30. DOI: 10.2165/00003495-200868050-00004. View

8.

Jacob S, Pidlaoan V, Singh J, Bharadwaj A, Patel M, Carrillo A . High defibrillation threshold: the science, signs and solutions. Indian Pacing Electrophysiol J. 2010; 10(1):21-39. PMC: 2803603. View

9.

Verma A, Kaplan A, Sarak B, Oosthuizen R, Beardsall M, Higgenbottam J . Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantation. J Interv Card Electrophysiol. 2010; 29(2):127-33. DOI: 10.1007/s10840-010-9511-7. View

10.

Haqqani H, Mond H . The implantable cardioverter-defibrillator lead: principles, progress, and promises. Pacing Clin Electrophysiol. 2009; 32(10):1336-53. DOI: 10.1111/j.1540-8159.2009.02492.x. View

11.

Mainigi S, Callans D . How to manage the patient with a high defibrillation threshold. Heart Rhythm. 2006; 3(4):492-5. DOI: 10.1016/j.hrthm.2005.12.023. View